In 2007, the CDC Advisory Committee on Immunization Practices (ACIP) recommended that Gardasil, the only FDA approved HPV vaccine, be administered to females ages 11 to 26 in the U.S. This recommendation became an automatic requirement for those applying for immigrant visas or adjustment to permanent residency status when the government updated its vaccination list in July 2008. Although the HPV vaccine has been deemed safe and effective by the FDA, it is not designed to combat the types of infectious diseases that the immigration requirements are intended to address. Moreover, the vaccine is prohibitively expensive-costing a minimum of $360 to receive the three-dose vaccination in addition to over $1,000 in filing fees-making the mandate an undue financial burden for prospective immigrant women and their families.

» Learn more

• HPV, Cervical Cancer, and API Women Issue Brief
• Sign-on Letter to CDC to Finalize Rule Removing HPV Vaccine Requirement
• Sign-on Letter to CDC Opposing HPV Vaccine Mandate for Immigrants
• NCIWR Statement on HPV Vaccine Mandate for Immigrants
• Joint Comment to CDC in Support of Criteria for Vaccination Requirements for U.S. Immigration Purposes

» Take Action! Say “No” to the Immigrant HPV Vaccine Mandate